Page last updated: 2024-12-06

cyclohexyl methylphosphonofluoridate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cyclohexyl methylphosphonofluoridate: acetylcholinesterase inhibitor [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID64505
CHEMBL ID4066149
SCHEMBL ID93674
MeSH IDM0152536

Synonyms (26)

Synonym
phosphonofluoridic acid, methyl-, cyclohexyl ester
cf me ester
cyclosin (chemical warfare agent)
brn 2327087
gf (chemical warfare agent)
o-cyclohexyl methylphosphonofluoridate
cyclohexyl methylphosphonofluoridate
methyl cyclohexylfluorophosphonate
ea 1212
cyclosarin
[fluoro(methyl)phosphoryl]oxycyclohexane
AKOS006277928
hsdb 7597
vm36f9n236 ,
329-99-7
unii-vm36f9n236
SCHEMBL93674
cyclosarin [hsdb]
SNTRKUOVAPUGAY-UHFFFAOYSA-N
cyclohexyl methylphosphonofluoridate (gf)
methylphosphonic acid, fluoroanhydride, cyclohexyl ester
cyclohexyl methylphosphonofluoridoate #
DTXSID00861875
Q418763
CHEMBL4066149
PD194891

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" LD50 of CMPF was estimated using an up-and-down dose selection procedure and 12 animals."( Evaluation of the toxicity, pathology, and treatment of cyclohexylmethylphosphonofluoridate (CMPF) poisoning in rhesus monkeys.
Dochterman, LW; Gresham, VC; Kaminskis, A; Koplovitz, I; Stewart, JR, 1992
)
0.28
" Animals were challenged with 5 x LD50 GF (233 micrograms/kg, IM) following pretreatment with pyridostigmine (0."( Acute toxicity of cyclohexylmethylphosphonofluoridate (CMPF) in rhesus monkeys: serum biochemical and hematologic changes.
Koplovitz, I; Young, GD, 1995
)
0.29
"A computer program (Q-test) was used to evaluate the combined toxic effects of nerve agent GF and its combined form with sarin (GB/GF) in mice."( Evaluation of combined toxic effects of GB/GF and efficacy of jielin injection against combined poisoning in mice.
Liang, J; Luo, C, 1997
)
0.3
" Empirical models, consisting of the toxic load model plus higher order terms, were developed and successfully fit to the data."( Inhalation toxicity of Cyclosarin (GF) vapor in rats as a function of exposure concentration and duration: potency comparison to sarin (GB).
Anthony, JS; Burnett, D; Crosier, R; Crouse, C; Gaviola, B; Haley, M; Manthei, J; Matson, K; Mioduszewski, R; Sommerville, D; Thomson, S; Way, R, 2004
)
0.32
"Cyclosarin (GF-agent; O-cyclohexylmethylfluorophosphonate) belongs to highly toxic organophosphorus compounds."( Signs of cyclosarin-induced neurotoxicity and its pharmacological treatment with quaternary pyridinium-oximes reactivators.
Bartosova, L; Krejcova-Kunesova, G; Kuca, K, 2005
)
0.33
"The potency of newly developed oximes (K074, K075) and commonly used oximes (obidoxime, trimedoxime, and HI-6) to counteract tabun or cyclosarin-induced acute toxic effects was studied in mice."( A comparison of the potency of newly developed oximes (K074, K075) and currently available oximes (obidoxime, trimedoxime, HI-6) to counteract acute toxic effects of tabun and cyclosarin in mice.
Humlicek, V; Kassa, J, 2008
)
0.35
" Recently, a chimeric PON1 mutant, IIG1, was engineered toward the hydrolysis of the toxic isomers of soman and cyclosarin with high in vitro catalytic efficiency."( Efficacy of the rePON1 mutant IIG1 to prevent cyclosarin toxicity in vivo and to detoxify structurally different nerve agents in vitro.
Ashani, Y; Goldsmith, M; Leader, H; Seeger, T; Sussman, JS; Tawfik, D; Thiermann, H; Wille, T; Worek, F, 2014
)
0.4
" In order to investigate the suitability of 6-OxP-CD as a small molecule scavenger an in vivo guinea pig model was established to determine the protective effect of 6-OxP-CD against the highly toxic nerve agent cyclosarin."( Effectiveness of a substituted β-cyclodextrin to prevent cyclosarin toxicity in vivo.
Kubik, S; Seeger, T; Thiermann, H; Wille, T; Worek, F; Zengerle, M, 2014
)
0.4

Pharmacokinetics

ExcerptReferenceRelevance
" HI-6 (500 mg 2Cl or 633 mg DMS) resulted in an identical pharmacokinetic profile unaffected by atropine co-administration."( The pharmacokinetics and pharmacodynamics of two HI-6 salts in swine and efficacy in the treatment of GF and soman poisoning.
Berger, BJ; Davidson, C; Hamilton, MG; Hill, I; Lecavalier, P; Lundy, PM; Vair, C; Weatherby, KL, 2005
)
0.33

Compound-Compound Interactions

ExcerptReferenceRelevance
"The effect of three newly developed bispyridinium non-oxime compounds (MB408, MB442, and MB444) on the therapeutic efficacy of a standard antidotal treatment (atropine in combination with the oxime HI-6 or obidoxime) of acute poisoning by two nerve agents (sarin and cyclosarin) in mice was studied."( Some benefit from non-oximes MB408, MB442 and MB444 in combination with the oximes HI-6 or obidoxime and atropine in antidoting sarin or cyclosarin poisoned mice.
Bird, M; Green, AC; Kassa, J; Tattersall, JEH; Timperley, CM; Williams, RL, 2018
)
0.48

Dosage Studied

ExcerptRelevanceReference
" The objectives of this study were to (1) generate GF vapor in a dynamic inhalation chamber system, starting in the lethal to near-lethal concentration range, (2) examine dose-response effects of inhaled GF vapor and analyze the relationship between concentration (C) and exposure duration (T) in determining probability of lethality, and (3) establish a lethal potency ratio between GF and the more volatile agent Sarin (GB)."( Inhalation toxicity of Cyclosarin (GF) vapor in rats as a function of exposure concentration and duration: potency comparison to sarin (GB).
Anthony, JS; Burnett, D; Crosier, R; Crouse, C; Gaviola, B; Haley, M; Manthei, J; Matson, K; Mioduszewski, R; Sommerville, D; Thomson, S; Way, R, 2004
)
0.32
" The calculations demonstrate the marked differences between oximes in dependence of the inhibitor and provide a basis for the estimation of the required oxime dose as well as of dosing intervals."( Estimation of oxime efficacy in nerve agent poisoning: a kinetic approach.
Szinicz, L; Thiermann, H; Worek, F, 2005
)
0.33
"The current studies estimated effective (miosis) concentrations of the nerve agents' sarin (GB) and cyclosarin (GF) as a function of exposure duration in the Gottingen minipig and determined dependency of the median effective dosage (ECT50) over time."( Comparison of low-level sarin and cyclosarin vapor exposure on pupil size of the Gottingen minipig: effects of exposure concentration and duration.
Benton, BJ; Crosier, RB; Dabisch, PA; Forster, JS; Hulet, SW; Jarvis, JR; Krauthauser, C; Miller, DB; Mioduszewski, RJ; Muse, WT; Reutter, SA; Scotto, JA; Sommerville, DR; Thomson, SA, 2006
)
0.33
"Findings suggest a dose-response association between low-level exposure to sarin and cyclosarin and specific functional central nervous system effects 4-5 years after exposure."( Effects of sarin and cyclosarin exposure during the 1991 Gulf War on neurobehavioral functioning in US army veterans.
Heaton, KJ; Heeren, T; Proctor, SP; White, RF, 2006
)
0.33
" The dose-response effects of 4-PA alone were also examined."( Effects of 4-pyridine aldoxime on nerve agent-inhibited acetylcholinesterase activity in guinea pigs.
McDonough, JH; Shih, TM; Skovira, JW, 2009
)
0.35
" There was no dose-response relationship between estimated levels of GB/GF exposure and brain volume."( Effects of low-level sarin and cyclosarin exposure and Gulf War Illness on brain structure and function: a study at 4T.
Abadjian, L; Chao, LL; Hlavin, J; Meyerhoff, DJ; Weiner, MW, 2011
)
0.37
"Acetylcholinesterase (AChE) reactivation studies were conducted in guinea pigs (GPs) and nonhuman primates (NHPs) to determine the 1,1'-methylenebis{4-[(hydroxyimino)methyl] pyridinium} dimethanesulfonate (MMB4 DMS) dose that reactivated at least 20% of blood AChE within 15 minutes following cyclosarin (GF) dosing (used as the criterion for efficacy)."( In vivo acetylcholinesterase reactivation in male guinea pigs and rhesus macaques following cyclosarin exposure and treatment with 1,1'-methylenebis{4-[(hydroxyimino)methyl] pyridinium} dimethanesulfonate.
Harvilchuck, JA; Hong, SP; Johnson, JD; Osheroff, MR; Richey, JS,
)
0.13
" There were no group difference in total hippocampal volume, quantified with FreeSurfer, and no dose-response relationship between estimated levels of GB/GF exposure and total hippocampal or subfield volume."( Effects of low-level sarin and cyclosarin exposure on hippocampal subfields in Gulf War Veterans.
Buckley, S; Chao, LL; Kriger, S; Mueller, SG; Ng, P, 2014
)
0.4
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1466205Inhibition of AChE in human erythrocyte assessed as ratio of k2/I using acetylthiocholine as substrate after 5 secs to 30 mins
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (132)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (0.76)18.7374
1990's11 (8.33)18.2507
2000's46 (34.85)29.6817
2010's63 (47.73)24.3611
2020's11 (8.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 15.97

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index15.97 (24.57)
Research Supply Index4.97 (2.92)
Research Growth Index5.76 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (15.97)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (2.10%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other140 (97.90%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]